Comparative analysis of COVID-19-related mortality risk in chronic lower respiratory disease and interstitial lung disease

##plugins.themes.themeTen.article.main##

George W. Hafzalla
Hyein Ji
Niranjan Jeganathan https://orcid.org/0000-0003-3561-2886

Keywords

COPD, ILD, COVID-19, mortality rate

Abstract 0 | PDF Downloads 0

References

1. Calver JF, Fabbri L, May J, Jenkins RG. COVID-19 in Patients with Chronic Lung Disease. Clin Chest Med 2023; 44: 385-393.
2. Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research. Multiple cause of death, 2018–2021. https://wonder.cdc.gov/mcd.html. .
3. Jeganathan N, Cleland D, Sathananthan M. The association of lung cancer with pulmonary fibrosis. ERJ Open Res 2022; 8.
4. Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med 2021; 9: 909-923.
5. Drake TM, Docherty AB, Harrison EM, et.al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. Am J Respir Crit Care Med 2020; 202: 1656-1665.
6. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med 2020; 8: 436-438.
7. Sanchez-Ramirez DC, Mackey D. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis. Respir Med 2020; 171: 106096.
8. Vasquez Reyes M. The Disproportional Impact of COVID-19 on African Americans. Health Hum Rights 2020; 22: 299-307.
9. Jeganathan N, Sathananthan M. Urban-Rural Differences in Idiopathic Pulmonary Fibrosis-Related Mortality Rates in the United States. Chest 2024; 165: 924-928.
10. Baughman RP, Lower EE. COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2021; 38: e2021029.
11. Baughman RP, Lower EE, Buchanan M, et al. Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire. Sarcoidosis Vasc Diffuse Lung Dis 2020; 37: e2020009.